Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion type Assertion NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_head.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion description "[Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_provenance.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion evidence source_evidence_literature NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_provenance.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion SIO_000772 24262285 NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_provenance.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion wasDerivedFrom befree-2016 NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_provenance.
- NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_assertion wasGeneratedBy ECO_0000203 NP1130396.RAL5rTvq-vQNWaUKdO--lXO_uRSFw3xqDncZ0D1P992Pk130_provenance.